Skip to main content
. 2018 May 1;11:97–103. doi: 10.2147/IMCRJ.S153918

Figure 1.

Figure 1

Bar graphs showing the different outcome measures before and after treatment with PRGF (OSDI [A], BCVA [B], and VAS severity–frequency of symptoms [CD]).

Note: *p<0.05.

Abbreviations: BCVA, best-corrected visual acuity; OSDI, ocular surface disease index; PRGF, plasma rich in growth factors; VAS, visual analog scale.